44
Miller LP, Lyeth BG, Jenkins LW, Oleniak L, Panchision D, Hamm RJ, Phillips LL, Dixon
CE, Clifton GL and Hayes RL. (1990). Excitatory amino acid receptor subtype
binding following traumatic brain injury. Brain Res. 526:103-107.
Milman A, Rosenberg A, Weizman R and Pick CG. (2005). Mild traumatic brain injury
induces persistent cognitive deficits and behavioral disturbances in mice. J
Neurotrauma. 22:1003-1010.
Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival:
application to proliferation and cytotoxicity assays. J Immunol Methods. 65:55-63.
Muir KW. (2006). Glutamate-based therapeutic approaches: clinical trials with NMDA
antagonists. Curr Opin Pharmacol. 6:53-60.
Muir KW and Lees KR. (1995). Clinical experience with excitatory amino acid antagonist
drugs. Stroke. 26:503-513.
Ogita K, Okuda H, Yamamoto Y, Nishiyama N and Yoneda Y. (2003). In vivo
neuroprotective role of NMDA receptors against kainate-induced excitotoxicity in
murine hippocampal pyramidal neurons. J Neurochem. 85:1336-1346.
Pagliaro P, Gattullo D, Rastaldo R and Losano G. (2001). Ischemic preconditioning:
from the first to the second window of protection. Life Sci. 69:1-15.
Piot-Grosjean O, Wahl F, Gobbo O and Stutzmann JM. (2001). Assessment of
sensorimotor and cognitive deficits induced by a moderate traumatic injury in the
right parietal cortex of the rat. Neurobiol Dis. 8:1082-1093.
Pohl D, Bittigau P, Ishimaru MJ, Stadthaus D, Hubner C, Olney JW, Turski L and
Ikonomidou C. (1999). N-Methyl-D-aspartate antagonists and apoptotic cell death
triggered by head trauma in developing rat brain. Proc Natl Acad Sci U S A.
96:2508-2513.
Raghupathi R. (2004). Cell death mechanisms following traumatic brain injury. Brain
Pathol. 14:215-222.
Rejdak R, Rejdak K, Sieklucka-Dziuba M, Stelmasiak Z and Grieb P. (2001). Brain
tolerance and preconditioning. Pol J Pharmacol. 53:73-79.
Roche KW, Standley S, McCallum J, Dune Ly C, Ehlers MD and Wenthold RJ. (2001).
Molecular determinants of NMDA receptor internalization. Nat Neurosci. 4:794-
802.
Rybnikova E, Vataeva L, Tyulkova E, Gluschenko T, Otellin V, Pelto-Huikko M and
Samoilov MO. (2005). Mild hypoxia preconditioning prevents impairment of
passive avoidance learning and suppression of brain NGFI-A expression induced
by severe hypoxia. Behav Brain Res. 160:107-114.
Saatman KE, Duhaime AC, Bullock R, Maas AI, Valadka A and Manley GT. (2008).
Classification of traumatic brain injury for targeted therapies. J Neurotrauma.
25:719-738.
Saleh MC, Connell BJ and Saleh TM. (2009). Ischemic tolerance following low dose
NMDA involves modulation of cellular stress proteins. Brain Res. 1247:212-220.
Sasahira M, Lowry T, Simon RP and Greenberg DA. (1995). Epileptic tolerance: prior
seizures protect against seizure-induced neuronal injury. Neurosci Lett. 185:95-
98.
Schumann J, Alexandrovich GA, Biegon A and Yaka R. (2008). Inhibition of NR2B
phosphorylation restores alterations in NMDA receptor expression and improves
functional recovery following traumatic brain injury in mice. J Neurotrauma.
25:945-957.